Bell Bank Reduces Stake in AbbVie by 12.2%

The bank now holds $12.09 million in shares of the pharmaceutical giant.

Mar. 29, 2026 at 8:03am

Got story updates? Submit your updates here. ›

Bell Bank lowered its position in AbbVie Inc. (NYSE:ABBV) by 12.2% in the fourth quarter, according to the company's latest SEC filing. The bank now owns 52,915 shares of AbbVie's stock, worth $12,091,000, making it the 25th largest holding in Bell Bank's investment portfolio.

Why it matters

AbbVie is a major pharmaceutical company with a diverse product portfolio, so changes in institutional ownership of its stock can provide insights into investor sentiment and market trends around the company.

The details

Bell Bank sold 7,333 shares of AbbVie during the quarter, reducing its total position by 12.2%. The bank now holds approximately 0.5% of its investment portfolio in AbbVie stock.

  • Bell Bank filed its 13F report for the fourth quarter of 2025 on March 29, 2026.

The players

Bell Bank

A regional bank based in North Dakota that manages a diversified investment portfolio.

AbbVie Inc.

A global biopharmaceutical company that focuses on developing therapies for complex and chronic medical conditions.

Got photos? Submit your photos here. ›

The takeaway

This filing indicates that Bell Bank has reduced its exposure to AbbVie, potentially signaling a shift in the bank's investment strategy or outlook on the pharmaceutical industry. However, AbbVie remains a sizable holding in Bell Bank's portfolio, suggesting the bank still sees long-term value in the company.